Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Mol Med ; 28(1): 90, 2022 08 03.
Article in English | MEDLINE | ID: mdl-35922766

ABSTRACT

BACKGROUND: Myoclonus, Epilepsy and Ragged-Red-Fibers (MERRF) is a mitochondrial encephalomyopathy due to heteroplasmic mutations in mitochondrial DNA (mtDNA) most frequently affecting the tRNALys gene at position m.8344A > G. Defective tRNALys severely impairs mitochondrial protein synthesis and respiratory chain when a high percentage of mutant heteroplasmy crosses the threshold for full-blown clinical phenotype. Therapy is currently limited to symptomatic management of myoclonic epilepsy, and supportive measures to counteract muscle weakness with co-factors/supplements. METHODS: We tested two therapeutic strategies to rescue mitochondrial function in cybrids and fibroblasts carrying different loads of the m.8344A > G mutation. The first strategy was aimed at inducing mitochondrial biogenesis directly, over-expressing the master regulator PGC-1α, or indirectly, through the treatment with nicotinic acid, a NAD+ precursor. The second was aimed at stimulating the removal of damaged mitochondria through prolonged rapamycin treatment. RESULTS: The first approach slightly increased mitochondrial protein expression and respiration in the wild type and intermediate-mutation load cells, but was ineffective in high-mutation load cell lines. This suggests that induction of mitochondrial biogenesis may not be sufficient to rescue mitochondrial dysfunction in MERRF cells with high-mutation load. The second approach, when administered chronically (4 weeks), induced a slight increase of mitochondrial respiration in fibroblasts with high-mutation load, and a significant improvement in fibroblasts with intermediate-mutation load, rescuing completely the bioenergetics defect. This effect was mediated by increased mitochondrial biogenesis, possibly related to the rapamycin-induced inhibition of the Mechanistic Target of Rapamycin Complex 1 (mTORC1) and the consequent activation of the Transcription Factor EB (TFEB). CONCLUSIONS: Overall, our results point to rapamycin-based therapy as a promising therapeutic option for MERRF.


Subject(s)
MERRF Syndrome , DNA, Mitochondrial/genetics , DNA, Mitochondrial/metabolism , Humans , MERRF Syndrome/genetics , MERRF Syndrome/metabolism , Mitochondria/genetics , Mitochondria/metabolism , Mitochondrial Proteins/genetics , Mitochondrial Proteins/metabolism , Mutation , RNA, Transfer, Lys/genetics , RNA, Transfer, Lys/metabolism , Sirolimus/metabolism , Sirolimus/pharmacology
2.
Proc Natl Acad Sci U S A ; 112(34): 10691-6, 2015 Aug 25.
Article in English | MEDLINE | ID: mdl-26261323

ABSTRACT

The cytoplasmic membrane is probably the most important physical barrier between microbes and the surrounding habitat. Aminoacylation of the polar head group of the phospholipid phosphatidylglycerol (PG) catalyzed by Ala-tRNA(Ala)-dependent alanyl-phosphatidylglycerol synthase (A-PGS) or by Lys-tRNA(Lys)-dependent lysyl-phosphatidylglycerol synthase (L-PGS) enables bacteria to cope with cationic peptides that are harmful to the integrity of the cell membrane. Accordingly, these synthases also have been designated as multiple peptide resistance factors (MprF). They consist of a separable C-terminal catalytic domain and an N-terminal transmembrane flippase domain. Here we present the X-ray crystallographic structure of the catalytic domain of A-PGS from the opportunistic human pathogen Pseudomonas aeruginosa. In parallel, the structure of the related lysyl-phosphatidylglycerol-specific L-PGS domain from Bacillus licheniformis in complex with the substrate analog L-lysine amide is presented. Both proteins reveal a continuous tunnel that allows the hydrophobic lipid substrate PG and the polar aminoacyl-tRNA substrate to access the catalytic site from opposite directions. Substrate recognition of A-PGS versus L-PGS was investigated using misacylated tRNA variants. The structural work presented here in combination with biochemical experiments using artificial tRNA or artificial lipid substrates reveals the tRNA acceptor stem, the aminoacyl moiety, and the polar head group of PG as the main determinants for substrate recognition. A mutagenesis approach yielded the complementary amino acid determinants of tRNA interaction. These results have broad implications for the design of L-PGS and A-PGS inhibitors that could render microbial pathogens more susceptible to antimicrobial compounds.


Subject(s)
Aminoacyltransferases/chemistry , Bacillus/enzymology , Bacterial Proteins/chemistry , Phosphatidylglycerols/metabolism , Pseudomonas aeruginosa/enzymology , R Factors , RNA, Transfer, Ala/metabolism , RNA, Transfer, Lys/metabolism , Aminoacylation , Aminoacyltransferases/metabolism , Bacillus/genetics , Bacterial Proteins/metabolism , Base Sequence , Catalytic Domain , Crystallography, X-Ray , Hydrophobic and Hydrophilic Interactions , Lysine/biosynthesis , Models, Molecular , Molecular Docking Simulation , Molecular Sequence Data , Mutagenesis, Site-Directed , Nucleic Acid Conformation , Phosphatidylglycerols/biosynthesis , Protein Conformation , Pseudomonas aeruginosa/genetics , Recombinant Fusion Proteins/chemistry , Structure-Activity Relationship , Substrate Specificity
3.
J Mol Biol ; 312(5): 985-97, 2001 Oct 05.
Article in English | MEDLINE | ID: mdl-11580244

ABSTRACT

Retroviral reverse transcriptases use host cellular tRNAs as primers to initiate reverse transcription. In the case of human immunodeficiency virus type 1 (HIV-1), the 3' 18 nucleotides of human tRNA(Lys,3) are annealed to a complementary sequence on the RNA genome known as the primer binding site (PBS). The HIV-1 nucleocapsid protein (NC) facilitates this annealing. To understand the structural changes that are induced upon NC binding to the tRNA alone, we employed a chemical probing method using the lanthanide metal terbium. At low concentrations of NC, the strong terbium cleavage observed in the core region of the tRNA is significantly attenuated. Thus, NC binding first results in disruption of the tRNA's metal binding pockets, including those that stabilize the D-TPsiC tertiary interaction. When NC concentrations approach the amount needed for complete primer/template annealing, NC further destabilizes the tRNA acceptor-TPsiC stem minihelix, as evidenced by increased terbium cleavage in this domain. A mutant form of NC (SSHS NC), which lacks the zinc finger structures, is able to anneal tRNA(Lys,3) efficiently to the PBS, and to destabilize the tRNA tertiary core, albeit less effectively than wild-type NC. This mutant form of NC does not affect cleavage significantly in the helical regions, even when bound at high concentrations. These results, as well as experiments conducted in the presence of polyLys, suggest that in the absence of the zinc finger structures, NC acts as a polycation, neutralizing the highly negative phosphodiester backbone. The presence of an effective multivalent cationic peptide is sufficient for efficient tRNA primer annealing to the PBS.


Subject(s)
HIV-1 , Nucleic Acid Conformation , Nucleocapsid/chemistry , Nucleocapsid/metabolism , RNA, Transfer, Lys/metabolism , RNA/metabolism , Zinc Fingers/physiology , Amino Acid Sequence , Base Sequence , Binding Sites , Humans , Lysine-tRNA Ligase/metabolism , Models, Molecular , Molecular Chaperones/chemistry , Molecular Chaperones/genetics , Molecular Chaperones/metabolism , Molecular Sequence Data , Mutation/genetics , Nucleic Acid Hybridization , Nucleocapsid/genetics , Polylysine/genetics , Polylysine/metabolism , Protein Binding , RNA/chemistry , RNA/genetics , RNA, Transfer, Lys/chemistry , RNA, Transfer, Lys/genetics , Templates, Genetic , Terbium/metabolism , Zinc Fingers/genetics
4.
Biol Pharm Bull ; 21(5): 474-8, 1998 May.
Article in English | MEDLINE | ID: mdl-9635503

ABSTRACT

The phylogenetic relationship of Atractylodes lancea, A. chinensis, A. koreana, A. ovata and A. japonica were analyzed by comparing the 2.6 kb sequence in a chloroplast gene trnK encoding tRNALys (UUU). The dried rhizomes of the former three species have been used as the crude drug "So-jutsu" and those of the latter two as "Byaku-jutsu" in Chinese and Japanese traditional medicine ("Kampo-medicine"). The trnK phylogenetic tree revealed that A. ovata is an outgroup of the five Atractylodes species examined and that A. japonica and A. lancea are most closely related. PCR amplification of trnK with HinfI digestion provided us with a simple method to distinguish A. ovata from other Atractylodes species at the molecular level.


Subject(s)
Chloroplasts/metabolism , Genes, Plant/genetics , Plants, Medicinal/classification , Base Sequence , Molecular Sequence Data , Open Reading Frames , Phylogeny , Plants, Medicinal/genetics , Plants, Medicinal/metabolism , Polymerase Chain Reaction , RNA, Transfer, Lys/metabolism
5.
Biochemistry ; 32(14): 3629-37, 1993 Apr 13.
Article in English | MEDLINE | ID: mdl-7682110

ABSTRACT

Six affinity reagents containing chemically reactive groups, either on the phosphate residue at the 5'-end or on the 5'- or 3'-end internucleoside phosphate linkages of the oligothymidylate primers, were used to covalently modify the human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT). After covalent binding of these modified primer analogs to the enzyme, the addition of [alpha-32P]dTTP, in the presence of a complementary template, led to elongation of the primer. This reaction was catalyzed by the active site of the enzyme carrying the covalently bound primer. The relative efficiency of labeling of the p66/p51 heterodimer compared to the p66/p66 and p51/p51 homodimers of HIV-1 RT was in agreement with the previously determined affinity of the various enzyme forms toward different primers. The analogues preferentially modified the p66 subunit of the HIV-1 RT heterodimer. The labeling of all RT forms by synthetic primer analogues showed significant and specific competition by the natural primer of HIV-1 RT, tRNA(Lys). In addition, the kinetics of inactivation of RT by primer analogues was studied. The affinity of the enzyme to those derivatives in the presence of poly(A) template was about 5-10 times higher than in the absence of template. Moreover, the maximal rates of HIV-1 RT inactivation by analogues in the absence of template were 3-4 times higher. Our results suggest that the mechanism of oligonucleotide primer binding to HIV-1 RT is different in the presence or absence of template.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Affinity Labels , HIV-1/enzymology , RNA-Directed DNA Polymerase/chemistry , Aldehydes/chemistry , Alkylation , Binding Sites , Binding, Competitive , HIV Reverse Transcriptase , Kinetics , Oligonucleotides/pharmacology , Phosphates/metabolism , RNA, Transfer, Lys/metabolism , RNA-Directed DNA Polymerase/metabolism , Reverse Transcriptase Inhibitors , Sulfhydryl Compounds/metabolism , Templates, Genetic , Thymidine Monophosphate/analogs & derivatives , Thymine Nucleotides/metabolism
6.
Proc Natl Acad Sci U S A ; 89(20): 9652-6, 1992 Oct 15.
Article in English | MEDLINE | ID: mdl-1384059

ABSTRACT

Although the reverse transcriptase (RT) of human immunodeficiency virus (HIV) uses human tRNA(3Lys) as a primer of viral genome DNA synthesis in vivo, HIV RT binds Escherichia coli glutamine tRNA and in vitro-made human lysine tRNA with nearly equivalent affinities. We show that HIV RT can use either tRNA(3Lys) or tRNA(2Gln) as a primer for DNA synthesis in vitro without the addition of any other host or viral proteins. E. coli tRNA(2Gln) can serve as a primer for HIV RT if a primer-binding site sequence complementary to the 3' end of tRNA(2Gln) is at the 3' end of the template. With this reduced template, the specificity of binding the proper tRNA is due to base-pairing between a bound tRNA to the primer-binding site of the viral RNA template rather than sequence-specific recognition of tRNA(3Lys) by RT. If an 8-nucleotide viral sequence 3' to the primer-binding site is included in the template, then addition of Zn2+ or Co2+ is required for tRNA(3Lys)-primed synthesis, and tRNA(2Gln) now fails to prime synthesis. The latter result implies that a template sequence adjacent to the primer-binding site and containing 6 nucleotides complementary to the anticodon loop of human tRNA(3Lys) plays an active role in tRNA discrimination.


Subject(s)
DNA Replication , HIV-1/enzymology , RNA, Transfer, Lys/metabolism , RNA-Directed DNA Polymerase/metabolism , Virus Replication , Base Sequence , Escherichia coli , HIV Reverse Transcriptase , HIV-1/growth & development , Humans , Molecular Sequence Data , RNA, Bacterial/metabolism , RNA, Transfer, Gln/metabolism , Substrate Specificity , Zinc/metabolism
7.
Nucleic Acids Res ; 20(8): 1959-65, 1992 Apr 25.
Article in English | MEDLINE | ID: mdl-1579498

ABSTRACT

Two-dimensional gel electrophoresis of HeLa cell prosomal RNAs, 3'-end labeled by RNA ligase, revealed one prominent spot. Determination of a partial sequence at the 3'-end indicated full homology to the 18 nucleotides at the 3'-end of tRNA(Lys,3) from rabbit, the bovine and the human species. An oligonucleotide complementary to the 3'-end of tRNA(Lys,3) hybridized on Northern blots with prosomal RNA from both HeLa cells and duck erythroblasts. In two-dimensional PAGE, the major pRNA of HeLa cells co-migrated with bovine tRNA(Lys,3). Reconstitution of the CCA 3'-end of RNA from both human and duck prosomes, by tRNA-nucleotidyl-transferase, confirmed the tRNA character of this type of RNA. Furthermore, it revealed at least one additional tRNA band about 85 nt long among the prosomal RNA from both species. Finally, confirming an original property of prosomal RNA, we show that in vitro synthesized tRNA(Lys,3) hybridizes stably to duck globin mRNA, and to poly(A)(+)- and poly(A)(-)-RNA from HeLa cells.


Subject(s)
RNA, Transfer, Lys/analysis , Ribonucleoproteins/chemistry , Animals , Base Sequence , Blotting, Northern , Ducks , Electrophoresis, Gel, Two-Dimensional , Erythroblasts , HeLa Cells , Humans , Molecular Sequence Data , RNA Nucleotidyltransferases/metabolism , RNA, Transfer, Lys/metabolism , Ribonucleoproteins/drug effects , Zinc/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL